Updated Jul 16, 2026
Teichmann Sarah A. has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $147K.
Sarah A. Teichmann is associated with 10x Genomics, Inc., a biotechnology company known for its innovative solutions in genomics. Specific details about her role and contributions to the company are not widely documented, indicating she may not be a public figure.
| Role | Insider |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-08 | TXG | 10x Genomics, Inc. | A — Grant or award | 8.8K | $0.00 | |
| 2026-02-27 | TXG | 10x Genomics, Inc. | S — Open-market sale [10b5-1] | 7.6K | $19.41 | $147K |
Sarah A. Teichmann is associated with 10x Genomics, Inc., a biotechnology company known for its innovative solutions in genomics. Specific details about her role and contributions to the company are not widely documented, indicating she may not be a public figure.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($147K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Teichmann Sarah A. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.